Crossref
Pitfalls of treating chronic myeloid leukaemia with dasatinib – pulmonary arterial hypertension as a rare complication
Transfuze a hematologie dnes · 2021
DOI: 10.48095/cctahd2021166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfuze a hematologie dnes, 2021. Verfasst von Petra Čičátková und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Čičátková, P., Kvetková, A., Horňák, T., Semerád, L., & Žáčková, D. (2021). Pitfalls of treating chronic myeloid leukaemia with dasatinib – pulmonary arterial hypertension as a rare complication. Transfuze a hematologie dnes. https://doi.org/10.48095/cctahd2021166
Vancouver
Čičátková P, Kvetková A, Horňák T, Semerád L, Žáčková D. Pitfalls of treating chronic myeloid leukaemia with dasatinib – pulmonary arterial hypertension as a rare complication. Transfuze a hematologie dnes. 2021. doi:10.48095/cctahd2021166
BibTeX
@article{itkov2021,
author = {Čičátková, Petra and Kvetková, Anežka and Horňák, Tomáš and Semerád, Lukáš and Žáčková, Daniela},
title = {Pitfalls of treating chronic myeloid leukaemia with dasatinib – pulmonary arterial hypertension as a rare complication},
journal = {Transfuze a hematologie dnes},
year = {2021},
doi = {10.48095/cctahd2021166}
}
EUVIMED